IDXG 8-K 2026-10-15

INTERPACE BIOSCIENCES, INC. (IDXG) 8-K dated 2026-10-15 — accession 0001493152-26-047090. This URL is the filing, not the IDXG hub.

INTERPACE BIOSCIENCES, INC. (IDXG) is a diagnostics & research company listed on OTCQX.

INTERPACE BIOSCIENCES, INC. filed a 8-K on 2026-10-15. Accession 0001493152-26-047090.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported IDXG revenue for 2025-12-31 was $38.7M. Net income was $24.6M. Revenue was down 17.5% from 2024-12-31 to 2025-12-31. IDXG currently screens at market cap $43.5M.

Not investment advice. The IDXG SEC hub lists recent forms. The stock page is the research view.